Movement and mood disorder in two brothers with Gaucher disease

Clinical Genetics

Volumn 72, Issue 4, 2007, Pages 357-361

  Raja, M ^a   Azzoni, A ^a   Giona, F ^b   Regis, S ^c   Grossi, S ^c   Filocamo, M ^c   Sidransky, Ellen ^d  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Gaucher disease; Glucocerebrosidase; Mood disorder; Parkinsonism

Indexed keywords

CHITOTRIOSIDASE; CITALOPRAM; DIAZEPAM; LEVODOPA; MIRTAZAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; FAMILY HISTORY; GAUCHER DISEASE; GENE MUTATION; GENE SEQUENCE; HOMOZYGOSITY; HUMAN; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

AGE OF ONSET; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; GAUCHER DISEASE; GENOTYPE; HUMANS; LYSOSOMAL STORAGE DISEASES; MALE; MIDDLE AGED; MOOD DISORDERS; MOVEMENT DISORDERS; PARKINSONIAN DISORDERS; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 34548548475     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00863.x     Document Type: Article

References (27)

1. Sidransky E. Gaucher disease: Complexity in a "simple"disorder. Mol Genet Metab 2004: 83: 6-15.
2. Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: Structure and evolution. Genomics 1989: 4: 87-96.
3. Hruska KS, LaMarca ME, Sidransky E. Gaucher disease: Molecular biology and genotype-phenotype correlations. In: Futerman AH, Zimran A, eds. Gaucher Disease. Boca Raton, FL: CRC Press, 2006: 13-48.
4. Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K. Gaucher disease with parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 2003: 79: 104-109.
5. Goker-Alpan O, Giasson BI, Eblan MJ et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 2006: 67: 908-910.
6. Filocamo M, Mazzotti R, Stroppiano M et al. Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients. Hum Mutat 2002: 20: 234-235.
7. Filocamo M, Bonuccelli G, Mazzotti R, Giona F, Gatti R. Identification of a novel recombinant allele in three unrelated Italian Gaucher patients: Implications for prognosis and genetic counseling. Blood Cells Mol Dis 2000: 26: 307.
8. Regis S, Grossi S, Lualdi S, Biancheri R, Filocamo M. Diagnosis of Pelizaeus-Merzbacher disease: Detection of proteolipid protein gene copy number by real-time PCR. Neurogenetics 2005: 6: 73-78.
9. Lachmann RH, Grant IR, Halsall D, Cox TM. Twin pairs showing discordance of phenotype in adult Gaucher's disease. QJM 2004: 97: 199-204.
10. Vellodi A, Bembi B, de Villemeur TB et al. Management of neuronopathic Gaucher disease: A European consensus. J Inherit Metab Dis 2001: 24: 319-327.
11. Tayebi N, Cushner S, Sidransky E. Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: implications for Gaucher disease. Am J Hum Genet 1996: 59: 740-741.
12. Rosenbaum H, Sidransky E. Cholelithiasis in patients with Gaucher disease. Blood Cells Mol Dis 2002: 28: 21-27.
13. Ben Harosh-Katz M, Patlas M, Hadas-Halpern I, Zimran A, Elstein D. Increased prevalence of cholelithiasis in GD: Association with splenectomy but not with Gilbert syndrome. J Clin Gastroenterol 2004: 38: 586-589.
14. Sack GH. Clinical diversity in Gaucher disease. Johns Hopkins Med J 1980: 146: 166-170.
15. McKeran RO, Bradbury P, Taylor D, Stern G. Neurological involvement in type I (adult) Gaucher disease. J Neurol Neurosurg Psychiatry 1985: 48: 172-175.
16. Turpin JC, Dubois G, Brice A et al. Parkinsonian symptomatology in a patient with type I (adult) Gaucher's disease. In: Salvayre R, Douste-Blazy L, Gatt S, eds. Lipid storage disorders: Biological and medical aspects. New York, NY: Plenum Press, 1987: 103-104.
17. Neudorfer O, Giladi N, Elstein D et al. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 1996: 89: 691-694.
18. Machaczka M, Rucinska M, Skotnicki AB, Jurczak W. Parkinson's syndrome preceding clinical manifestations of Gaucher's disease. Am J Hematol 1999: 61: 216-217.
19. Tayebi N, Callahan M, Madike V et al. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 2001: 73: 313-321.
20. Bembi B, Zambito Marsala S, Sidransky E et al. Gaucher's disease with Parkinson's disease: Clinical and pathological aspects. Neurology 2003: 61: 99-101.
21. Guimaraes J, Amaral O, Sa Miranda MC. Adult-onset neuronopathic form of Gaucher's disease: A case report. Parkinsonism Relat Disord 2003: 9: 261-264.
22. Wong K, Sidransky E, Verma A et al. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 2004: 82: 192-207.
23. Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. J Med Genet 2004: 41: 937-940.
24. Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 81: 2004: 70-73.
25. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004: 351: 1972-1977.
26. Clark LN, Nicolai A, Afridi S et al. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord 2005: 20: 100-103.
27. Sato C, Morgan A, Lang AE et al. Analysis of the glucocerebrosidase gene in Parkinson's disease. Mov Disord 2005: 20: 367-370.